Heather Bresch
Investors demand resignation of Mylan executives over pay packages
June 29, 2017Sales and Marketing Heather Bresch, Mylan, epipen
As confidence in Mylan continues to fall and share prices plummet after last year’s EpiPen pricing scandal and subsequent PR …
Mylan agrees $465m settlement over EpiPen misclassification
October 10, 2016Business Services, Medical Communications, Sales and Marketing Heather Bresch, Mylan, Price hike, epipen
In the latest scandal in the EpiPen price hike saga, the US Department of Justice has made claims that the …
“Incorrect classification” of EpiPen leads to $1 billion bill for US government
October 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, Heather Bresch, Misclassification, Mylan, Price hike, classification, epipen, price, scandal
Mylan’s EpiPen woes show no sign of abating after CMS (Centers for Medicare and Medicaid Services) released figures that show …
Price-hiked EpiPen profits 66% higher than Mylan CEO claimed
September 27, 2016Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen
In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …
EpiPen CEO appears before US lawmakers to defend “sickening” price hikes
September 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen
Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …
Mylan announces Momenta collaboration to develop six biosimilars
January 8, 2016Manufacturing and Production, Sales and Marketing Heather Bresch, Momenta, Mylan, biosimilars
Mylan has entered an exclusive global collaboration agreement with Momenta Pharmaceuticals, to develop, manufacture and commercialise six of Momenta’s biosimilar …
Latest content
FibroFind appoints Lee Borthwick as CEO
